MDxHealth Completes Bio Techne ExoDx Acquisition to Bolster Precision Diagnostics [Yahoo! Finance]
MDxHealth SA (MDXH)
Company Research
Source: Yahoo! Finance
15, 2025, MDxHealth SA (NASDAQ:MDXH) announced the completion of its acquisition of Bio-Techne Corporation's ExoDx business, including the ExoDx Prostate test. This $15 million transaction is part of the company's plan to strengthen its precision diagnostics portfolio. Earlier on August 5, 2025, MDxHealth SA (NASDAQ:MDXH) signed a definitive agreement for the takeover with payment structured over the next few years. Under the terms, $5 million in stock will be paid at closing, while $2.5 million will be paid annually in the course of four years, half in cash and half in either cash or stock, at the company's discretion. Overall, MDxHealth SA (NASDAQ:MDXH) offers a diverse range of precision diagnostics, targeting all stages of prostate cancer and advanced UTI detection, a market worth $4.9 billion in itself. Despite potential competition from big names, the company's “sticky adoption” is an incredibly bullish hint. MDxHealth SA (NASDAQ:MDXH), headquartered in Herstal, Belgium, i
Show less
Read more
Impact Snapshot
Event Time:
MDXH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDXH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDXH alerts
High impacting MDxHealth SA news events
Weekly update
A roundup of the hottest topics
MDXH
News
- Institutions profited after MDxHealth SA's (NASDAQ:MDXH) market cap rose US$17m last week but retail investors profited the most [Yahoo! Finance]Yahoo! Finance
- MDxHealth (NASDAQ:MDXH) had its price target raised by analysts at TD Cowen from $5.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
- MDxHealth (NASDAQ:MDXH) had its price target raised by analysts at Lake Street Capital from $7.00 to $9.00. They now have a "buy" rating on the stock.MarketBeat
- MDxHealth (NASDAQ:MDXH) had its price target raised by analysts at BTIG Research from $6.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
- MDxHealth SA (MDXH) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
MDXH
Earnings
- 11/12/25 - Miss
MDXH
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/12/25 - Form 6-K
- 9/16/25 - Form 6-K
- MDXH's page on the SEC website